Bronchiolitis Clinical Trials
4 recruiting trials for Bronchiolitis. Eligibility criteria explained in plain English.
TrialFinderData lists 4 Bronchiolitis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Laboratoire de la Mer (1), Assistance Publique - Hôpitaux de Paris (1), Children's Hospital of Soochow University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Respimer® Hygiene-Prevention -Baby, kids, adults (device, 1 trial), followed by Respimer® Hygiene-Prevention Kids, adults, Respimer® Decongestion Baby, kids, adults.
Track Bronchiolitis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms
The purpose of this post-market clinical investigation is to assess in a real-life setting, the effectiveness, usage, tolerance, safety and satisfaction of 4 isotonic and...
Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants
Acute bronchiolitis is a common disease in children under the age of two, caused mainly by the respiratory syncytial virus (RSV). Furthermore, given the same medical history, it...
Peginterferon α-2b Injection for the Treatment of Pediatric RSV Bronchiolitis
This is a multicenter, randomized, positive-controlled, non-inferiority clinical study, planning to enroll 90 children with bronchiolitis caused by respiratory syncytial virus...
Pediatric and Ambulatory Research in Infectious Diseases
Many ambulatory networks are mainly based on diagnoses made by first-line physicians not specifically trained to join the network. Here we aim to set up a surveillance network on...
Explore Other Conditions
Frequently Asked Questions
There are currently 4 clinical trials for Bronchiolitis, with 4 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Bronchiolitis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Bronchiolitis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.